Jane Street Group, LLC Idera Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 17, 2022	SELL	$0.41 - $0.7 $19,843 - $33,879	-48,399 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.53 - $1.03 $17,782 - $34,558	33,552 Added 225.99%	48,399 $28,000
Q3 2021 Nov 16, 2021	BUY	$1.0 - $1.18 $1,841 - $2,172	1,841 Added 14.16%	14,847 $15,000
Q2 2021 Aug 16, 2021	BUY	$1.01 - $1.58 $13,136 - $20,549	13,006 New	13,006 $15,000
Q4 2020 Feb 17, 2021	SELL	$2.09 - $5.18 $21,207 - $52,561	-10,147 Closed	0 $0

Q3 2020 Nov 17, 2020	BUY	$1.71 - $2.68 $17,351 - $27,193	10,147 New	10,147 $22,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $3.31 $187,848 - $293,292	-88,608 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$2.37 - $3.97 $210,000 - $351,773	88,608 New	88,608 $237,000
Q1 2019 May 16, 2019	SELL	$2.33 - $3.79 $33,193 - $53,992	-14,246 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$2.77 - $9.38 $39,461 - $133,627	14,246 New	14,246 $39,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.